Roche posts SKYSCRAPER-01 results for tiragolumab/atezolizumab; registers Phase II Parkinson's trialNov 13Weekly roundup, 9 itemsalectinibastegolimab
FDA's zanubrutinib record expands with CLL/SLL approval detailNov 10Regulatory decisionBeiGenezanubrutinibUpdated
Roche registers giredestrant Phase 3 trial; six other studies updateNov 6Weekly roundup, 16 itemsAbbViealectinibUpdated
Aurinia starts PRESERVE trial combining LUPKYNIS with biologics in lupus nephritisOct 30Quarterly updateAurinia Pharmaceuticals Inc.voclosporin
Artiva Biotherapeutics halts AlloNK development, cuts staff by 94%Oct 27Quarterly updateArtiva Biotherapeutics, Inc.Biogen
AbbVie posts results for Japan CLL/SLL study; also files new Phase 3 NSCLC trial vs pembrolizumabOct 23Weekly roundup, 6 itemsABBV-1480AbbVieUpdated
BeOne Medicines registers Phase 1 trial of BG-T0050 in DLBCL and other B-cell cancersOct 21Weekly roundup, 5 itemsazacitidineBeiGene
Genentech registers Phase I trial of RO7890597 in healthy volunteersSep 2Weekly roundup, 3 itemsBeiGeneobinutuzumab
Aurinia starts PRESERVE trial combining LUPKYNIS with biologics in lupus nephritisAug 6Quarterly updateAurinia Pharmaceuticals Inc.voclosporin
Ocrevus higher-dose Phase 3 posts results, misses primary endpoint; two partner trials updateJul 24Weekly roundup, 4 itemsobinutuzumabocrelizumab